Prospective Clinicogenomic Program

Cancer
Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer

For Medical Professional
Download
Print

Basic Details

Sponsor Genentech, Inc.

Phase Phase 4

Trial Identifier NCT04180176, GX41563

Condition Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC)

Official Title A Multicenter, Low-Interventional Study to Evaluate the Feasibility of a Prospective Clinicogenomic Program

Study Summary

The main purpose of this study is to evaluate the feasibility of a scalable, prospective research program for participants with metastatic non-small cell lung cancer (mNSCLC) or extensive-stage small-cell lung cancer (ES-SCLC) planning to start standard-of-care (SOC) systemic anti-cancer treatment. The study will also examine ctDNA status over the course of treatment as a predictor of response to therapy.

Eligibility Criteria

Gender

All

Age

≥18 Years

Healthy Volunteers

Inclusion Criteria

Documented diagnosis of mNSCLC or ES-SCLC
Planned initiation of SOC systemic anti-cancer treatment
Front-Line Immunotherapy Cohort: Received front-line treatment of an immune blockade therapy including anti-CTLA-4, anti-PD-1, or anti-PD-L1 therapeutic antibody on Protocol GX41563

Exclusion Criteria

Participant actively receiving investigational medicinal product(s) as part of an interventional trial at the time of signing informed consent

This page summarises information from public registry websites, such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. To learn more about this study, see the For Medical Professional tab or visit one of those websites.

The information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.

Results Disclaimer

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

Prospective Clinicogenomic Program

Basic Details

Study Summary

Eligibility Criteria

Inclusion Criteria

Exclusion Criteria

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Contact Genentech

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

Prospective Clinicogenomic Program

For the latest version of this information please go to www.forpatients.roche.com